BiotechTube
Qnovia

Qnovia

Richmond, United States· Est.
qnovia.com
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $17M

Overview

Qnovia, founded in 2019 and based in Richmond, USA, is a private, pre-revenue biotech company developing a disruptive inhaled drug delivery platform. The company's core technology is positioned as a versatile platform capable of delivering various drugs, with its lead application targeting smoking cessation, for which it has an active IND and is pursuing FDA and MHRA approvals. Led by founder and CEO Mario Danek and supported by a team with deep regulatory and commercial experience, including former FDA Center for Tobacco Products director Mitch Zeller, Qnovia aims to partner with larger healthcare companies to bring its technology to market.

Smoking CessationRespiratory

Technology Platform

Proprietary inhaled drug delivery platform designed to optimize dosing, track adherence, increase efficacy, and improve patient compliance for a broad range of pharmaceuticals.

Funding History

1
Total raised:$17M
Seed$17M

Opportunities

The global smoking cessation market represents a multi-billion dollar initial addressable market with a high unmet need for more effective therapies.
The platform's potential application to other respiratory and systemic diseases offers a substantial long-term pipeline opportunity through partnerships with large pharmaceutical companies.

Risk Factors

The company faces significant clinical and regulatory risk in proving its platform's safety and efficacy for its lead indication.
As a pre-revenue company dependent on external financing, it also carries high financial and execution risk in a competitive market.

Competitive Landscape

Qnovia competes in the smoking cessation space against large OTC NRT brands (e.g., Nicorette), prescription drugs (e.g., Chantix), and digital health tools. As a platform, it would also compete with established drug delivery device companies (e.g., Kindeva, 3M, Aptar) and connected inhaler startups (e.g., Propeller Health, now part of ResMed).

More companies in United States →